European Archives - Page 506 of 1370 - European Medical Journal

Fatty Acid Imbalance Links to Severe Psoriasis

New findings have identified a link between elevated concentrations of saturated and monosaturated fatty acids and greater severity of psoriasis.

Breast Cancer Overtreatment Avoided by Using Electronic Prompts

Electronic health record-based prompts have been shown to halve the rate of unnecessary surgery in older patients with early-stage breast cancer.

Labour government to allow researchers broader access to NHS data

Researchers and pharmaceutical companies could get wider access to NHS data for the first time under new Labour plans.

ViiV Healthcare’s Harmony Garges on giving voice to people with HIV

Dr Harmony Garges, Chief Medical Officer, ViiV Healthcare, discusses how best to serve patients of all ages living with HIV around the world.

Optimising pharma's customer experience journey

Customer experience is a key driver of product adoption in any industry – and this is no exception for the pharmaceutical realm.

A Roadmap for Multiple Myeloma CAR-T Referral

Explore this educational infographic to learn how to best identify and prepare patients for CAR-T therapy and the key considerations behind..

Irritable Bowel Syndrome and Dyspepsia Following Acute Gastroenteritis

Research explores the prevalence of post-infection irritable bowel syndrome and functional dyspepsia after acute gastroenteritis.

Metabolic and Physiological Changes May Predict Pancreatic Cancer Diagnosis

Changes in body composition and metabolic markers could enable the early detection of pancreatic ductal adenocarcinoma.

Effects of Persistent Smoking on Cancer Care Explored

A new study stresses the importance of a universal screening and opt-out referral strategy that may mitigate disparities in tobacco treatment access and use in cancer care.

Disparities in Next-Generation Sequencing in Metastatic Prostate and Urothelial Cancers

A new study highlights significant disparities in next-generation sequencing testing among patients with metastatic prostate cancer and advanced urothelial carcinoma.